Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Treasury Shares (2021 - 2025)

NeuroPace has reported Treasury Shares over the past 5 years, most recently at $5.3 million for Q4 2025.

  • Quarterly results put Treasury Shares at $5.3 million for Q4 2025, up 256.06% from a year ago — trailing twelve months through Dec 2025 was $5.3 million (up 256.06% YoY), and the annual figure for FY2025 was $5.3 million, up 256.06%.
  • Treasury Shares for Q4 2025 was $5.3 million at NeuroPace, up from $1.4 million in the prior quarter.
  • Over the last five years, Treasury Shares for NPCE hit a ceiling of $5.3 million in Q1 2025 and a floor of $1282.0 in Q2 2024.
  • Median Treasury Shares over the past 5 years was $1.6 million (2024), compared with a mean of $1.8 million.
  • Peak annual rise in Treasury Shares hit 168009.78% in 2024, while the deepest fall reached 99.96% in 2024.
  • NeuroPace's Treasury Shares stood at $596085.0 in 2021, then surged by 194.62% to $1.8 million in 2022, then surged by 38.41% to $2.4 million in 2023, then crashed by 39.1% to $1.5 million in 2024, then skyrocketed by 256.06% to $5.3 million in 2025.
  • The last three reported values for Treasury Shares were $5.3 million (Q4 2025), $1.4 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.